1. Habib Dable

    0 Comments Leave a Comment

    1-4 of 4
    1. Mentioned In 4 Articles

    2. PepGen Appoints Habib Dable to Board of Directors

      PepGen Appoints Habib Dable to Board of Directors
      PepGen Inc. (PepGen), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Habib Joseph Dable to its Board of Directors. Mr. Dable is the former President and Chief Executive Officer of Acceleron Pharma, and brings nearly three decades of experience working with emerging biotech and big pharma companies...
      Read Full Article
    3. Blueprint Medicines Appoints Habib Dable to its Board of Directors

      Blueprint Medicines Appoints Habib Dable to its Board of Directors
      Blueprint Medicines Corporation (NASDAQ:BPMC) today announced the appointment ofHabib Dableto its board of directors. Mr. Dable, who was Chief Executive Officer of Acceleron Pharma from 2016 to 2021, brings nearly 30 years of experience in strategic leadership, commercial growth and organizational scale across global pharmaceutical and emerging biotechnology companies...
      Read Full Article
    4. 1-4 of 4
  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content